![Barbara Weber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Weber
Patrimonio netto: 14 M $ in data 31/12/2025
Profilo
Barbara L.
Weber is President, Chief Executive Officer & Director at Tango Therapeutics Sub, Inc. since 2017.
Executive Chairman at Tango Therapeutics, Inc. starting in 2026.
Director at Parabilis Medicines, Inc. since 2018.
Independent Director at OPY Acquisition Corp.
I since 2021.
Member of the American Society for Clinical Investigation and the American Association of Physician Specialists, Inc. Formerly Independent Director at Revolution Medicines, Inc. from 2018 to 2025.
Director at the American Society of Clinical Oncology, Inc. and the American Association for Cancer Research.
Venture Partner at Third Rock Ventures LLC.
Senior VP-Oncology Translational Medicine at Novartis AG from 2009 to 2015.
Professor & Associate at the University of Pennsylvania from 1994 to 2005.
Assistant Professor at the University of Michigan from 1988 to 1994.
VP-Oncology Discovery & Translational Medicine at GlaxoSmithKline LLC from 2005 to 2009.
Chief Medical Officer at BioNTech US, Inc. from 2015 to 2017.
Education includes a doctorate from UW Medicine conferred in 1978 and an undergraduate degree from the University of Washington conferred in 1978.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2025 | 1.456.344 ( 1,08% ) | 13 M $ | 31/12/2025 | |
| 31/03/2025 | 8.817 ( 0% ) | 702 274 $ | 31/12/2025 |
Posizioni attive di Barbara Weber
| Società | Posizione | Inizio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Presidente | 08/01/2026 |
| OPY ACQUISITION CORP. I | Direttore/Membro del Consiglio | 01/10/2021 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
American Association of Physician Specialists, Inc.
 American Association of Physician Specialists, Inc. Operates as an association of physicians | Corporate Officer/Principal | - |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. Develops transformational new drugs for cancer patients | Amministratore Delegato | 01/03/2017 |
Parabilis Medicines
 Parabilis Medicines Operates as a clinical-stage biopharmaceutical company that delivers medicines to people with cancer | Direttore/Membro del Consiglio | 25/10/2018 |
Precedenti posizioni note di Barbara Weber
| Società | Posizione | Fine |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Direttore/Membro del Consiglio | 18/06/2025 |
| NEON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2015 |
| ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Barbara Weber
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
UW Medicine
 UW Medicine Functions as a College/University | |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Develops new therapies derived from natural products | |
BioNTech US, Inc.
 BioNTech US, Inc. Develops novel therapeutics leveraging neoantigen biology to treat cancer | |
Parabilis Medicines
Parabilis Medicines Operates as a clinical-stage biopharmaceutical company that delivers medicines to people with cancer | |
American Association of Physician Specialists, Inc.
American Association of Physician Specialists, Inc. Operates as an association of physicians | |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. Develops transformational new drugs for cancer patients | |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | |
OPY Acquisition Corp. I
 OPY Acquisition Corp. I Operates as a blank check company |
